(64)Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients

BACKGROUND: The purpose of this study was to determine whether brain metastases from HER2-positive breast cancer could be detected noninvasively using positron emission tomography (PET) with (64)Cu-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-trastuzumab. METHODS: PET was performe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:EJNMMI Res
Autors principals: Kurihara, Hiroaki, Hamada, Akinobu, Yoshida, Masayuki, Shimma, Schuichi, Hashimoto, Jun, Yonemori, Kan, Tani, Hitomi, Miyakita, Yasuji, Kanayama, Yousuke, Wada, Yasuhiro, Kodaira, Makoto, Yunokawa, Mayu, Yamamoto, Harukaze, Shimizu, Chikako, Takahashi, Kazuhiro, Watanabe, Yasuyoshi, Fujiwara, Yasuhiro, Tamura, Kenji
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2015
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4385241/
https://ncbi.nlm.nih.gov/pubmed/25853014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-015-0082-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars